Status:
COMPLETED
Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
Lead Sponsor:
Watson Pharmaceuticals
Conditions:
Healthy Volunteers
Eligibility:
All Genders
60-79 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.
Eligibility Criteria
Inclusion
- Males and females aged 60 and over
- English as a primary language
- Given written informed consent by signing and dating an informed consent form prior to study entry
Exclusion
- Current diseases in which the use of oxybutynin is contraindicated
- History of narrow-angle glaucoma or urinary or gastric retention
- Current use of drugs known to effect memory and cognition
- Other protocol-defined inclusion/exclusion criteria may apply
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT00752141
Start Date
September 1 2008
Last Update
September 23 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson, Arizona, United States, 85741-3656
2
National City, California, United States, 91950
3
Maitland, Florida, United States, 32751
4
Naples, Florida, United States, 34102